On July 10th, Good Neighbor Pharmacy
, along with 200+ pharmacy and patient stakeholders, sent a letter
to U.S. Sens. Chuck Grassley (R-IA), Chairman of the Senate Finance Committee, and Ron Wyden (D-OR), Ranking Member of the Finance Committee, urging them to address pharmacy DIR fees in drug pricing legislation this year. The signatories stressed that if CMS will not act to address DIR fees, then it is critical for Congress to take action. ABC and GNP’s pharmacy experts will continue to advocate for DIR fee reform for pharmacy and Medicare beneficiaries.